News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,767 Results
Type
Article (13945)
Company Profile (24)
Press Release (179798)
Section
Business (54362)
Career Advice (614)
Deals (10652)
Drug Delivery (30)
Drug Development (29529)
Employer Resources (70)
FDA (5135)
Job Trends (4226)
News (100804)
Policy (8841)
Tag
Academia (1075)
Alliances (15035)
Alzheimer's disease (433)
Approvals (5141)
Artificial intelligence (49)
Bankruptcy (73)
Best Places to Work (3371)
Breast cancer (71)
Cancer (482)
Cardiovascular disease (43)
Career advice (513)
CAR-T (39)
Cell therapy (104)
Clinical research (24943)
Collaboration (150)
COVID-19 (1086)
C-suite (44)
Data (587)
Diabetes (80)
Diagnostics (1761)
Drug pricing (35)
Earnings (16571)
Employer resources (64)
Events (23076)
Executive appointments (179)
FDA (5398)
Funding (169)
Gene therapy (71)
GLP-1 (251)
Government (1189)
Healthcare (5657)
Infectious disease (1123)
Inflammatory bowel disease (50)
Interviews (103)
IPO (3932)
Job creations (989)
Job search strategy (454)
Layoffs (79)
Legal (1938)
Lung cancer (57)
Manufacturing (64)
Medical device (3348)
Medtech (3350)
Mergers & acquisitions (6844)
Metabolic disorders (187)
Neuroscience (579)
NextGen: Class of 2025 (2038)
Non-profit (1639)
Northern California (437)
Obesity (88)
Opinion (45)
Parkinson's disease (46)
People (18994)
Phase I (5604)
Phase II (10648)
Phase III (10086)
Pipeline (194)
Policy (38)
Postmarket research (1293)
Preclinical (2002)
Radiopharmaceuticals (72)
Rare diseases (87)
Real estate (1496)
Regulatory (6252)
Research institute (907)
Resumes & cover letters (82)
Series A (42)
Southern California (408)
Startups (1248)
United States (4250)
Vaccines (269)
Weight loss (62)
Date
Today (26)
Last 7 days (160)
Last 30 days (768)
Last 365 days (9096)
2025 (1237)
2024 (9160)
2023 (10540)
2022 (15318)
2021 (16565)
2020 (15759)
2019 (14455)
2018 (11159)
2017 (10526)
2016 (10130)
2015 (12213)
2014 (8430)
2013 (6478)
2012 (6926)
2011 (7206)
2010 (6285)
Location
Africa (262)
Arizona (39)
Asia (12980)
Australia (2444)
California (1012)
Canada (339)
China (119)
Colorado (49)
Connecticut (46)
Europe (43722)
Florida (146)
Georgia (61)
Illinois (134)
Indiana (70)
Japan (52)
Maryland (208)
Massachusetts (747)
Michigan (35)
Minnesota (74)
New Jersey (353)
New York (407)
North Carolina (202)
Northern California (437)
Pennsylvania (265)
South America (393)
Southern California (408)
Texas (119)
Washington State (148)
193,767 Results for "avacta group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024
·
3 min read
Press Releases
Avacta Appoints Brian Hahn as Chief Financial Officer
January 14, 2025
·
3 min read
Press Releases
Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers
January 16, 2025
·
6 min read
Press Releases
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
October 21, 2024
·
4 min read
Press Releases
Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform
October 17, 2024
·
4 min read
Press Releases
Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
October 25, 2024
·
8 min read
Drug Development
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
Avacta Group plc announces that the first patient has been dosed in the US under its Investigational New Drug (IND) Application in Avacta’s phase 1 multi-centre trial evaluating the safety and tolerability of AVA6000, a novel tumour targeted form of doxorubicin and Avacta’s first therapeutic product based on its proprietary pre|CISION™ technology.
April 27, 2023
·
1 min read
Press Releases
Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium
October 10, 2024
·
5 min read
Press Releases
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
September 9, 2024
·
2 min read
Business
Appointment of Chief Business Officer
19 December 2023 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Appointment of Chief Business Officer.
December 19, 2023
·
4 min read
1 of 19,377
Next
